Literature DB >> 32016018

MicroRNA targeting energy metabolism in ovarian cancer: a potent contender for future therapeutics.

Siddhika Pareek1, Aritro Nath2, R Stephanie Huang1.   

Abstract

Entities:  

Year:  2019        PMID： 32016018      PMCID： PMC6976402          DOI： 10.21037/atm.2019.11.15

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  11 in total

1.  miR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism.

Authors:  Bruna Rodrigues Muys; Josane F Sousa; Jessica Rodrigues Plaça; Luíza Ferreira de Araújo; Aishe A Sarshad; Dimitrios G Anastasakis; Xiantao Wang; Xiao Ling Li; Greice Andreotti de Molfetta; Anelisa Ramão; Ashish Lal; Daniel Onofre Vidal; Markus Hafner; Wilson A Silva
Journal:  Cancer Res       Date:  2019-05-17       Impact factor: 12.701

2.  EMT in cancer.

Authors:  Thomas Brabletz; Raghu Kalluri; M Angela Nieto; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2018-01-12       Impact factor: 60.716

Review 3.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

4.  Glutaminase inhibitor compound 968 inhibits cell proliferation and sensitizes paclitaxel in ovarian cancer.

Authors:  Lingqin Yuan; Xiugui Sheng; Leslie H Clark; Lu Zhang; Hui Guo; Hannah M Jones; Adam K Willson; Paola A Gehrig; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

5.  Metabolic changes during ovarian cancer progression as targets for sphingosine treatment.

Authors:  Angela S Anderson; Paul C Roberts; Madlyn I Frisard; Ryan P McMillan; Timothy J Brown; Michael H Lawless; Matthew W Hulver; Eva M Schmelz
Journal:  Exp Cell Res       Date:  2013-03-19       Impact factor: 3.905

6.  Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway.

Authors:  Lingqin Yuan; Xiugui Sheng; Adam K Willson; Dario R Roque; Jessica E Stine; Hui Guo; Hannah M Jones; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Endocr Relat Cancer       Date:  2015-06-04       Impact factor: 5.678

7.  Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer.

Authors:  Lifeng Yang; Tyler Moss; Lingegowda S Mangala; Juan Marini; Hongyun Zhao; Stephen Wahlig; Guillermo Armaiz-Pena; Dahai Jiang; Abhinav Achreja; Julia Win; Rajesha Roopaimoole; Cristian Rodriguez-Aguayo; Imelda Mercado-Uribe; Gabriel Lopez-Berestein; Jinsong Liu; Takashi Tsukamoto; Anil K Sood; Prahlad T Ram; Deepak Nagrath
Journal:  Mol Syst Biol       Date:  2014-05-05       Impact factor: 11.429

Review 8.  Emerging and Evolving Ovarian Cancer Animal Models.

Authors:  Alexander S Bobbs; Jennifer M Cole; Karen D Cowden Dahl
Journal:  Cancer Growth Metastasis       Date:  2015-08-12

Review 9.  Fundamentals of cancer metabolism.

Authors:  Ralph J DeBerardinis; Navdeep S Chandel
Journal:  Sci Adv       Date:  2016-05-27       Impact factor: 14.136

10.  Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer.

Authors:  Li Sun; Yajie Yin; Leslie H Clark; Wenchuan Sun; Stephanie A Sullivan; Arthur-Quan Tran; Jianjun Han; Lu Zhang; Hui Guo; Esther Madugu; Tommy Pan; Amanda L Jackson; Joshua Kilgore; Hannah M Jones; Timothy P Gilliam; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Oncotarget       Date:  2017-06-29
View more
  1 in total

1.  Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer.

Authors:  Aritro Nath; Patrick A Cosgrove; Hoda Mirsafian; Elizabeth L Christie; Lance Pflieger; Benjamin Copeland; Sumana Majumdar; Mihaela C Cristea; Ernest S Han; Stephen J Lee; Edward W Wang; Sian Fereday; Nadia Traficante; Ravi Salgia; Theresa Werner; Adam L Cohen; Philip Moos; Jeffrey T Chang; David D L Bowtell; Andrea H Bild
Journal:  Nat Commun       Date:  2021-05-24       Impact factor: 14.919
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.